Pacira BioSciences (PCRX) Interest & Investment Income (2010 - 2026)

Pacira BioSciences' Interest & Investment Income history runs 17 years deep, the most recent figure standing at $1.9 million for Q1 2026.

• In Q1 2026, Interest & Investment Income fell 72.01% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $17.8 million (down 21.67% YoY), while the FY2025 annual figure was $22.7 million, up 15.46% from the prior year.
• Interest & Investment Income was $1.9 million for Q1 2026 at Pacira BioSciences, down from $2.3 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $8.5 million in Q3 2025 to a low of $252000.0 in Q2 2022.
• Historically, Interest & Investment Income has averaged $3.5 million across 5 years, with a median of $3.1 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Interest & Investment Income soared 3381.25% in 2022, then plunged 72.01% in 2026.
• A 5-year view of Interest & Investment Income shows it stood at $2.8 million in 2022, then gained by 22.98% to $3.4 million in 2023, then jumped by 62.19% to $5.6 million in 2024, then plunged by 58.69% to $2.3 million in 2025, then dropped by 15.9% to $1.9 million in 2026.
• The last three Interest & Investment Income figures came in at $1.9 million (Q1 2026), $2.3 million (Q4 2025), and $8.5 million (Q3 2025), per Business Quant data.